Gastro protective and anti-Helicobacter Pylori effects of a flavonoid rich fraction obtained from Achyrocline Satureoides (LAM) D.C

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 7, 2014, Pages 417-422

  Santin, José Roberto ^a   Marivanelemos, ^a   Klein Júnior, Luiz Carlos ^a   De Oliveira Silveira, Alessandro Conrado ^a,b   Petreanu, Marcel ^a   Zermiani, Tailyn ^a   Cruz, Alexandre Bella ^a   Doniero, Rival ^a   De Andrade, Sérgiofaloni ^a  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

^b REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

Author keywords

Achyrocline satureoides; Flavonoids; Gastroprotective; Helicobacter pylori

Indexed keywords

ALCOHOL; CARBENOXOLONE; CIMETIDINE; FLAVANOID; FLAVONOID; LUTEOLIN; N (G) NITROARGININE METHYL ESTER; N ETHYLMALEIMIDE; OMEPRAZOLE; QUERCETIN; QUERCETIN 3 METHYL ETHER; UNCLASSIFIED DRUG;

ACHYROCLINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HELICOBACTER PYLORI; LIQUID CHROMATOGRAPHY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PHYTOCHEMISTRY; RAT; STOMACH MUCOSA INJURY; STOMACH MUCUS; STOMACH PROTECTION; ULCER HEALING;

EID: 84905450194     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Naik Y, Jayaram S, Harish Nayaka MA, Lakshman, Dharmesh SM. Gastroprotective effect of swallow root (Decalepis hamiltonii) extract:possible involvement of H(+)-K(+)-ATPase inhibition and antioxidative mechanism. J Ethnopharmacol 2007;112(1):173-9.
2. Klein LC, Gandolfi RB, Santin JR, Lemos M, Cechinel Filho V, de Andrade SF. Antiulcerogenic activity of extract, fractions, and some compounds obtained from Polygala cyparissias St. Hillaire &Moquin (Polygalaceae) J Naunyn-Schmiedeberg's Archives of Pharmacology 2010;381(2):121-6.
3. Santin JR, Niero R, Andrade SF, Cechinel-Filho V. Klein-Júnior LC, The therapeutic lead potential of metabolites obtained from natural sources for the treatment of peptic ulcer J Phytochem Rev 2012;11:567-616.
4. Daufenback S, Rodrigues SF, LinsGaldino S, Pitta ISI, Teixeira S, Muscará MN, da Rocha Farsky SH, Role of an indole-thiazolidine molecule PPAR pan-agonist and COX inhibitor on inflammation and microcirculatory damage inacute gastric lesions. PLo e76894 2013;8.
5. Bornschein J, Malfertheiner P. Helicobacter pylori and gastric cancer. Digestive diseases (Basel, Switzerland) 2014; 32(3): 249-64.
6. Castillo-Juárez I, González V, Jaime-Aguilar H, Martínez G, Linares E, Bye R, et al. Anti-Helicobacter pylori activity of plants used in Mexican traditional medicine for gastrointestinal disorders. J Ethnopharmacol 2009;122(2):402-5.
7. Malfertheiner P, Chan FKL, McColl KEL. Peptic ulcer disease. J Lancet 2009;374(9699):1449-61.
8. Lin P-C, Chang C-H, Hsu P-I, Tseng P-L, Huang Y-B. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients:a meta-analysis. J Crit Care Med 2010;38(4):1197-205.
9. Gugliucci A, Menini T. Three different pathways for human LDL oxidation are inhibited in vitro by water extracts of the medicinal herb Achyrocline satureoides. J Life Sci 2002;71(6):693-705.
10. Kadarian C, Broussalis AM, Miño J, Lopez P, Gorzalczany S, Ferraro G, et al. Hepatoprotective activity of Achyrocline satureioides(Lam) D. C. J Pharma Res Society 2002;45(1):57-61.
11. Arredondo MF, Blasina F, Echeverry C, Morquio A, Ferreira M, Abin-Carriquiry JA, et al. Cytoprotection by Achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress. J Ethnopharmacol 2004;91(1):13-20.
12. Cosentino M, Bombelli R, Carcano E, Luini A, Marino F, Crema F, et al. Immunomodulatory properties of Achyrocline satureioides (Lam.) D.C. infusion:a study on human leukocytes. J Ethnopharmacol 2008;116(3):501-7.
13. Vitto LA, Petenatti EM, Petenenatti ME, Mazza SM, Marchevsky EJ, J. Del Major and trace elements contents in crude drug and infusions of two south American species of Achyrocline (Asteraceae) named "Marcelas". Lat Am. Can J Physiol Pharmacol 2009;28:552-9.
14. Santin JR, Lemos M, Klein Júnior LC, Niero R, de Andrade SF. Antiulcer effects of Achyrocline satureoides (Lam.) DC (Asteraceae) (Marcela), a folk medicine plant, in different experimental models. J Ethnopharmacol 2010;130(2):334-9.
15. Barioni ED, Santin JR, Machado ID, Rodrigues SF, Ferraz-de-Paula V, Wagner TM, et al. Corrêa Dos SantosM, Achyrocline satureioides (Lam.) D.C. Hydroalcoholic Extract Inhibits Neutrophil Functions Related to Innate Host Defense2013.
16. Morimoto Y, Shimohara K, Oshima S, Sukamoto T. Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine. J Pharmacol 1991;57(4):495-505.
17. Nwafor PA, Okwuasaba FK, Binda LG. Antidiarrhoeal and antiulcerogenic effects of methanolic extract of Asparagus pubescens root in rats. J Ethnopharmacol 2000;72(3):421-7.
18. Takagi K, Okabe S, Saziki R. A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing. J Pharmacol 1969;19(3):418-26.
19. Shay H, Komarov SA, Fels SS, Meranze D, Gruenstein M, Siplet H. A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 1945;5:43-61.
20. Sun XB, Matsumoto T, Yamada H. Effects of a polysaccharide fraction from the roots of Bupleurum falcatum L. on experimental gastric ulcer models in rats and mice. The Journal of pharmacy and pharmacology 1991;43(10):699-704.
21. Matsuda H, Li Y, Yoshikawa M. Roles of capsaicin-sensitive sensory nerves, endogenous nitric oxide, sulfhydryls, and prostaglandins in gastroprotection by momordin Ic, an oleanolic acid oligoglycoside, on ethanol-induced gastric mucosal lesions in rats. J Life Sci 1999;65(2):PL27-32.
22. Murray PR, M. AS. Manual of Clinical Microbiology2006.
23. Wayne PA. CLSI-Clinical and Laboratory Standards Institute, Methods for Determining Bactericidal Activity of Antimicrobial Agents. National Committee for Clinical Laboratory Standards 2007.
24. Bidone J, Bica VC, Petrovick PR, Simoes CMO, Koester LS, Bassani VL, et al. Simultaneous quantification of flavonoids from Achyrocline satureioides by a polar-reversed phase LC method--application to skin permeation/retention studies. Die Pharmazie 2014;69(1):5-9.
25. Guslandi M. Effects of ethanol on the gastric mucosa. Digestive diseases (Basel, Switzerland) 1987;5(1):21-32.
26. Filho VC, Niero R, Clasen BK, Balogun SO, Martins DT, Simabaferruginea A, et al. De Souza AlmeidaES, de Oliveira Pharmacological mechanisms underlying the anti-ulcer activity of methanol extract and canthin-6-one of St-Hil. in animal models 2011;134:630-6.
27. Brzozowski T, Konturek PC, Sliwowski Z, Kwiecień S, Drozdowicz D, Pawlik M, et al. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. Journal of physiology and pharmacology:an official journal of the Polish Physiological Society 2006;57 Suppl 3:67-79.
28. Shimoyama AT, Santin JR, Machado ID, de Oliveira e Silva AM, de Melo ILP, Mancini-Filho J, et al. Antiulcerogenic activity of chlorogenic acid in different models of gastric ulcer. Naunyn-Schmiedeberg's archives of pharmacology 2013;386(1):5-14.
29. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection:why doesn't the stomach digest itself? Physiol Rev 2008;88(4):1547-65.
30. Wang L, Zhou Y, Peng J, Zhang Z, Jiang D-J, Li Y-J. Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury. Can J Physiol Pharmacol 2008;86(3):97-104.
31. Avila JR, de la Lastra CA, Martin MJ, Motilva V, Luque I, Delgado D, et al. Role of endogenous sulphydryls and neutrophil infiltration in the pathogenesis of gastric mucosal injury induced by piroxicam in rats. Inflammation research:official journal of the European Histamine Research Society [et al] 1996;45(2):83-8.
32. Garza-González E, Perez-Perez GI, Maldonado-Garza HJ, Bosques-Padilla FJ. A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. World J Gastroenterology:WJG 2014;20(6):1438-49.